Indication
Gaucher's Disease Type I
2 clinical trials
4 products
Clinical trial
Open Label, Two Cohort (With and Without Imiglucerase), Multicenter Study to Evaluate Pharmacokinetics, Safety, and Efficacy of Eliglustat in Pediatric Patients With Gaucher Disease Type 1 and Type 3Status: Active (not recruiting), Estimated PCD: 2025-11-20
Product
ImigluceraseProduct
EliglustatClinical trial
An Open-Label Study to Evaluate the Absolute Bioavailability of Genz-112638 and the Absorption, Metabolism, and Excretion of [14C]-Genz-112638 in Male SubjectsStatus: Completed, Estimated PCD: 2009-07-05
Product
[14C]-Genz-112638Product
Genz-112638